Manulife (Manufacturers Life Insurance)’s Sagimet Biosciences SGMT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Buy	+15,308	New	+$104K	﹤0.01%	2709

Other funds holding SGMT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SGMT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 15,308 shares worth $118K. The stake represents ﹤0.01% of the portfolio and ranks #2709 among its holdings.

122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

Manulife (Manufacturers Life Insurance) held 15,308 shares of Sagimet Biosciences worth $118K as of Q2 2026.
Sagimet Biosciences was a new Manulife (Manufacturers Life Insurance) position in Q2 2026.
Sagimet Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2709 holding.
122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.